This article is more than 5 years old. Information may no longer be current.

$2.7M NIH grant to aid Bioptigen's pediatric ophthalmology research

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

RESEARCH TRIANGLE PARK, N.C. — The U.S. National Institutes of Health has awarded a $2.7 million, 27-month grant to Bioptigen to investigate technologies that could be applied to the research, diagnosis and treatment of childhood eye diseases, according to a press release from Bioptigen.

Bioptigen will use the grant, awarded via the NIH's National Eye Institute, to study targeting of spectral-domain optical coherence tomography to the pediatric population. The research will focus on developing a compact, handheld device to provide structural and functional imaging of premature and neonatal infants, according to the release.

"Children have unique eye care needs," Eric L. Buckland, PhD, president and CEO of Bioptigen, said in the release. "It is both exciting and satisfying to work on imaging tailored to the developing eye. Our objective is to provide researchers and clinicians with the comprehensive, mobile imaging they require to properly view and manage pediatric eye disease."